Hives

Low vision — poor eyesight that can’t be corrected by glasses, contact lenses, surgery or medication — afflicts more than 2 million Americans, according to the National Eye Institute (NEI). But this is a conservative estimate. Some 14 million Americans suffer from visual impairment if you include those with eye problems that hamper the performance...

In this study, the researchers sought to determine the features of age-related macular degeneration (AMD) in the Black Barbadian population. A random group of Barbados-born citizens 40 to 84 years of age was selected. A total of 3,444 participants completed examinations at the study site and had gradable macular photographs taken of both eyes. Data were...

Age-related macular degeneration (AMD) is the leading cause of legal blindness in elderly individuals in Western countries. In this study, researchers sought answers regarding whether or not people who consume alcohol have a higher risk of developing AMD. A prospective study was conducted of 32,764 female nurses and 29,488 male health professionals who were 50...

Recently, the anti-interleukin-5 antibody drugs mepolizumab and benralizumab have been approved for severe asthma. The purpose of this study was to analyze the way that patients respond to mepolizumab and benralizumab with respect to a few key indicators and metrics. In particular, the study focused on three bioindicators of airway hyperresponsiveness and remodeling: L-selectin, Krebs...

Article by. Gerardo Sison Genetic testing is at the forefront of precision medicine and state-of-the-art treatments for cancer. Precision medicine is a valuable part of oncology as it allows cancer patients to receive targeted treatment, avoid adverse events, and experience optimal outcomes. Through precision medicine, physicians can apply more comprehensive treatment methods that revolve around...

Nearly 60 million patients in the United States live with disabilities.1 Although patients with disabilities show high engagement with health care services and represent about one-quarter of health care expenditures in the U.S.,2 this large group remains underrepresented in clinical research trials. As a result, any treatments or therapies developed from these trials may not...